Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis

Maritsa Margaroni,1,2 Maria Agallou,1 Evita Athanasiou,1 Olga Kammona,3 Costas Kiparissides,3,4 Catherine Gaitanaki,2 Evdokia Karagouni1 1Laboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute, 2Department of Animal and Human Physiology, School of Biology, Nationa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Margaroni M, Agallou M, Athanasiou E, Kammona O, Kiparissides C, Gaitanaki C, Karagouni E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
PLGA NPs
soluble Leishmania antigen
visceral leishmaniasis
vaccine
T cells
cytokines
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/b00d0dacdc704e70843050777f62da25
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b00d0dacdc704e70843050777f62da25

Ejemplares similares